Alger Fund Family Report
|
Performance
12-31-18
Total ReturnCategory
Average
| Total Return | 5.11 | 0.59 | 30.77 | -0.20 | -- |
| Category Average | 2.94 | 3.63 | 27.17 | -3.28 | 7.04 |
| Assets for Each Yr* | 15.56 | 13.56 | 15.88 | 15.94 | 15.94 |
*billions
Trailing Returns %
12-31-18
| YTD | 3 Year | 5 Year | |||
|---|---|---|---|---|---|
| Fund Family | -0.20 | 9.50 | 8.74 | ||
Key Stats
12-31-18
| Total Assets* | Min. Investment | Load (% of Assets) | No Load (% of Assets) |
|---|---|---|---|
| $15,942 mil | $1,000 | 30.50 | 69.50 |
| Asset Class | Score | % of Assets | Expense Ratio % | Expense Rating |
| Domestic Stock | 3.8 | 96.92 | 1.28 | Average |
| International Stock | 1.2 | 1.10 | 1.49 | Above Avg |
| Municipal Bond | -- | -- | -- | -- |
| Taxable Bond | -- | -- | -- | -- |
*Doesn't include money market assets.
Top 20 US Holdings | Get Price Quotes
01-18-19
| Sector | YTD Return % | % Net Assets | ||
|---|---|---|---|---|
| Microsoft Corp* | Technology | 6.05 | 6.87 | |
| Amazon.com Inc* | Consumer Cyclical | 12.93 | 6.22 | |
| Alphabet Inc Class C* | Technology | 6.05 | 4.04 | |
| Apple Inc* | Technology | -0.58 | 3.97 | |
| UnitedHealth Group Inc* | Healthcare | 6.58 | 3.82 | |
| Salesforce.com Inc* | Technology | 11.35 | 2.62 | |
| Facebook Inc A* | Technology | 14.46 | 2.01 | |
| Adobe Inc* | Technology | 9.40 | 2.00 | |
| Boston Scientific Corp* | Healthcare | 6.65 | 1.51 | |
| The Home Depot Inc* | Consumer Cyclical | 4.52 | 1.40 | |
| Vertex Pharmaceuticals Inc* | Healthcare | 17.49 | 1.40 | |
| PayPal Holdings Inc* | Financial Services | 8.36 | 1.31 | |
| Illumina Inc* | Healthcare | 4.27 | 1.27 | |
| Altaba Inc* | Financial Services | 11.56 | 1.25 | |
| Boeing Co* | Industrials | 13.09 | 1.15 | |
| Thermo Fisher Scientific Inc* | Healthcare | 7.54 | 1.13 | |
| Abbott Laboratories* | Healthcare | -0.82 | 1.07 | |
| Walt Disney Co* | Consumer Cyclical | 1.27 | 0.92 | |
| Abiomed Inc* | Healthcare | 2.68 | 0.91 | |
| Lam Research Corp* | Technology | 8.36 | 0.89 | |
Best 5-Year Relative Performance | More
01-18-19
| Fund Name | 5-Yr Rank | Analyst Report | ||
|---|---|---|---|---|
| Alger Small Cap Focus I | 3 | 05-15-18 | ||
| Alger Balanced I-2 | 10 | -- | ||
| Alger Health Sciences A | 13 | -- | ||
| Alger Focus Equity I | 14 | -- | ||
| Alger SMid Cap Focus I-2 | 17 | -- | ||
Worst 5-Year Relative Performance | More
01-18-19
| Fund Name | 5-Yr Rank | Analyst Report | ||
|---|---|---|---|---|
| Alger International Focus B | 100 | -- | ||
| Alger Global Focus A | 82 | -- | ||
| Alger Responsible Investing | 80 | -- | ||
| Alger Mid Cap Growth B | 78 | -- | ||
| Alger Emerging Markets I | 77 | -- | ||
Lowest Expenses | More
01-18-19
| Fund Name | Expense Ratio | Analyst Report | ||
|---|---|---|---|---|
| Alger 35 P | 0.40 | -- | ||
| Alger 25 P | 0.75 | -- | ||
| Alger Large Cap Growth I-2 | 0.88 | -- | ||
| Alger Capital Appreciation P | 0.94 | 12-05-18 | ||
| Alger Growth & Income I-2 | 0.94 | -- | ||
Highest Expenses | More
01-18-19
| Fund Name | Expense Ratio | Analyst Report | ||
|---|---|---|---|---|
| Alger Dynamic Opportunities | 2.63 | -- | ||
| Alger Small Cap Growth B | 2.23 | -- | ||
| Alger Mid Cap Growth B | 2.05 | -- | ||
| Alger International Focus B | 2.01 | -- | ||
| Alger Capital Appreciation B | 1.99 | 12-05-18 | ||
Longest Manager Tenure | More
01-18-19
| Fund Name | Manager Name | Avg Manager Tenure | ||
|---|---|---|---|---|
| Alger Large Cap Grow | Daniel C. Chung | 17.30 | ||
| Alger Growth & Incom | Daniel C. Chung | 11.10 | ||
| Alger Capital Apprec | Patrick Kelly | 9.00 | ||
| Alger Capital Apprec | Patrick Kelly | 9.00 | ||
| Alger Capital Apprec | Patrick Kelly | 9.00 | ||
Shortest Manager Tenure | More
01-18-19
| Fund Name | Manager Name | Avg Manager Tenure | ||
|---|---|---|---|---|
| Alger 35 P | Daniel C. Chung | 0.80 | ||
| Alger Global Focus A | Gregory M. Jones | 0.80 | ||
| Alger International | Gregory M. Jones | 0.80 | ||
| Alger 25 P | Ankur Crawford | 1.10 | ||
| Alger SMid Cap Focus | Joshua D. Bennett | 1.90 | ||